Noradrenergic modulation of subthalamic nucleus activity: Behavioral and electrophysiological evidence in intact and 6-hydroxydopamine-lesioned rats

被引:53
作者
Belujon, Pauline [1 ]
Bezard, Erwan [1 ]
Taupignon, Anne [1 ]
Bioulac, Bernard [1 ]
Benazzouz, Abdelhamid [1 ]
机构
[1] Univ Victor Segalen, CNRS, UMR 5227, F-33076 Bordeaux, France
关键词
norepinephrine (noradrenergic); subthalamic nucleus; Parkinson's disease; locomotor activity; extracellular recordings; 6-hydroxydopamine;
D O I
10.1523/JNEUROSCI.2583-07.2007
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The subthalamic nucleus ( STN) plays a key role in the pathophysiology of Parkinson's disease. The modulation of the STN by norepinephrine, however, is unknown. The present study aims at characterizing the effects of systemic administration of noradrenergic agents on locomotor activity and on in vivo extracellularly recorded STN neuronal activity in intact and 6-hydroxydopamine ( 6-OHDA)-lesioned rats. Using selective agonists and antagonists of alpha 1 and alpha 2 adrenergic receptors ( ARs), we show that STN neurons have functional alpha 1- and alpha 2-AR controlling STN firing with an impact on locomotor activity. We further demonstrate that those systemic effects are supported, at least in part, by a direct modulation of STN neuronal activity, using patch-clamp recordings of STN neurons in brain slices. These findings support the premise that hypokinesia is associated with an increased STN neuronal activity, and that improvements of parkinsonian motor abnormalities are associated with a decrease inSTNactivity. Our data challenge assumptions about the role of alpha 1-AR and alpha 2-AR in the regulation of STN neurons in both intact and 6-OHDA-lesioned rats and further ground the rationale for using alpha 2-AR noradrenergic antagonists in Parkinson's disease, albeit via an unexpected mechanism.
引用
收藏
页码:9595 / 9606
页数:12
相关论文
共 83 条
[1]  
ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119
[2]  
Antonelli T, 1991, Boll Soc Ital Biol Sper, V67, P965
[3]   Noradrenaline increases the firing rate of a subpopulation of rat subthalamic neurones through the activation of α1-adrenoceptors [J].
Arcos, D ;
Sierra, A ;
Nuñez, A ;
Flores, G ;
Aceves, J ;
Arias-Montaño, JA .
NEUROPHARMACOLOGY, 2003, 45 (08) :1070-1079
[4]  
Awad H, 2000, J NEUROSCI, V20, P7871
[5]   Effects of transient focal inactivation of the basal ganglia in parkinsonian primates [J].
Baron, MS ;
Wichmann, T ;
Ma, DM ;
Delong, MR .
JOURNAL OF NEUROSCIENCE, 2002, 22 (02) :592-599
[6]   Activation of GABAA receptors in subthalamic neurons in vitro:: Properties of native receptors and inhibition mechanisms [J].
Baufreton, J ;
Garret, M ;
Dovero, S ;
Dufy, B ;
Bioulac, B ;
Taupignon, A .
JOURNAL OF NEUROPHYSIOLOGY, 2001, 86 (01) :75-85
[7]  
Baufreton J, 2003, J NEUROSCI, V23, P816
[8]   REVERSAL OF RIGIDITY AND IMPROVEMENT IN MOTOR-PERFORMANCE BY SUBTHALAMIC HIGH-FREQUENCY STIMULATION IN MPTP-TREATED MONKEYS [J].
BENAZZOUZ, A ;
GROSS, C ;
FEGER, J ;
BORAUD, T ;
BIOULAC, B .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1993, 5 (04) :382-389
[9]   THE PRIMATE SUBTHALAMIC NUCLEUS .2. NEURONAL-ACTIVITY IN THE MPTP MODEL OF PARKINSONISM [J].
BERGMAN, H ;
WICHMANN, T ;
KARMON, B ;
DELONG, MR .
JOURNAL OF NEUROPHYSIOLOGY, 1994, 72 (02) :507-520
[10]   REVERSAL OF EXPERIMENTAL PARKINSONISM BY LESIONS OF THE SUBTHALAMIC NUCLEUS [J].
BERGMAN, H ;
WICHMANN, T ;
DELONG, MR .
SCIENCE, 1990, 249 (4975) :1436-1438